We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

57 hedge funds and large institutions have $94.4M invested in Akebia Therapeutics in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $391K | Put options by funds: $107K

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

12% more funds holding

Funds holding: 51 → 57 (+6)

44% less capital invested

Capital invested by funds: $170M → $94.4M (-$75.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
19
Reduced
13
Closed
8
Calls
$391K
Puts
$107K
Net Calls
+$284K
Net Calls Change
-$1.54M

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$11.2M
2
BFA
BlackRock Fund Advisors
California
+$3.86M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.28M
4
Millennium Management
Millennium Management
New York
+$1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$964K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$4.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.04M
3
Jennison Associates
Jennison Associates
New York
-$3.97M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.95M
5
EAM
Eventide Asset Management
Massachusetts
-$3.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
51
Edge Wealth Management
New York
$6K +$7.17K +500 New
Barclays
52
Barclays
United Kingdom
$4K +$5.22K +364 +449%
BlackRock
53
BlackRock
New York
$3K – – –
Teacher Retirement System of Texas
54
Teacher Retirement System of Texas
Texas
$3K +$3.96K +276 New
WA
55
WFG Advisors
Texas
$1K – – –
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
$1K +$717 +50 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$18 -$57.7K -4,022 -72%
Jennison Associates
58
Jennison Associates
New York
– -$3.97M -179,232 Closed
EAM
59
Eventide Asset Management
Massachusetts
– -$3.68M -166,200 Closed
SFM
60
Sphera Funds Management
Israel
– -$1.99M -89,817 Closed
VAM
61
Visium Asset Management
New York
– -$1.66M -74,768 Closed
AI
62
Axiom Investors
Connecticut
– -$677K -30,600 Closed
BPC
63
Banque Pictet & Cie
Switzerland
– -$300K -13,553 Closed
SFPIA
64
Stevens First Principles Investment Advisors
California
– -$19K -850 Closed
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
– -$13K -586 Closed
1 2
3

AKBA Hedge Fund Activity: Q4 2014 in Review

57 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q4 2014, worth a combined $94.4M — down 44% from $170M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AKBA positions and 8 closed out — a net gain of 8 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Franklin Resources, cutting an estimated $4.8M.

  • 57 institutional investors held Akebia Therapeutics (AKBA) as of Q4 2014, up from 51 in Q3 2014.
  • Funds reported $94.4M of Akebia Therapeutics stock for Q4 2014, down 44% quarter-over-quarter.
  • 16 funds opened new Akebia Therapeutics positions in Q4 2014 and 8 closed out, a net change of +8 holders.
  • The largest Akebia Therapeutics buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest Akebia Therapeutics seller in Q4 2014 was Franklin Resources, an estimated $4.8M sold.

Based on aggregated 13F filings for Q4 2014.